蛋白质纳米颗粒:在儿童瘤学中减少化疗肺部并发症的一个有希望的前沿
Hadi Zare-Zardini1, Fatemeh Dehghanpour2,3, Elham Saberian4
1Department of Biomedical Engineering, Meybod University, Meybod, Iran. hadizarezardini@gmail.com.
Biomedical engineering online
|November 28, 2025
概括
蛋白质纳米颗粒提供了一种有希望的策略,以减少儿童的化疗诱导的肺损伤. 量身定制的纳米粒子尺寸和受控释放改善了儿科瘤患者的药物输送和安全性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 儿科瘤学 儿科瘤学
背景情况:
- 化疗经常导致儿童癌症患者严重的肺部并发症.
- 目前的治疗方法缺乏向的治疗,导致全身毒性.
- 蛋白质纳米颗粒 (NP) 提供了一种新的方法来减轻这些副作用.
研究的目的:
- 审查蛋白质NP在儿科瘤学中用于向化疗的使用.
- 通过控制释放来研究NP如何降低肺毒性.
- 讨论年龄特定的NP优化和未来的方向.
主要方法:
- 关于儿童肺部毒性的蛋白质NP现有文献的叙述性综述.
- 对不同蛋白质来源 (白蛋白,丝纤维素,凝等) 的分析. 对于NP配方而言.
- 基于肺部发育的特定年龄的NP大小要求的检查.
主要成果:
- 专NP显示出优越的生物相容性;植物蛋白提供了具有成本效益的替代品.
- 针对不同儿科年龄组提出了量身定制的NP尺寸 (50-500nm).
- 在临床前研究中,受控释放动力学显著降低了炎症标志物.
结论:
- 在儿科瘤学中,蛋白NP可以有效地减轻化疗诱导的肺毒性.
- 在监管批准和可扩展制造方面仍然存在挑战.
- 到2030年,个性化NP疗法和人工智能驱动的配方可能将严重的肺部并发症减少50%.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
524
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
524